- Home
- IAG vs HALO Comparison
IAG vs HALO Comparison
Compare IAG & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAG
- HALO
- Stock Information
- Founded
- IAG 1990
- HALO 1998
- Country
- IAG Canada
- HALO United States
- Employees
- IAG N/A
- HALO N/A
- Industry
- IAG Precious Metals
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IAG Basic Materials
- HALO Health Care
- Exchange
- IAG Nasdaq
- HALO Nasdaq
- Market Cap
- IAG 7.1B
- HALO 7.6B
- IPO Year
- IAG 1996
- HALO N/A
- Fundamental
- Price
- IAG $12.18
- HALO $67.92
- Analyst Decision
- IAG Buy
- HALO Buy
- Analyst Count
- IAG 4
- HALO 11
- Target Price
- IAG $15.25
- HALO $74.91
- AVG Volume (30 Days)
- IAG 12.9M
- HALO 1.7M
- Earning Date
- IAG 11-04-2025
- HALO 11-03-2025
- Dividend Yield
- IAG N/A
- HALO N/A
- EPS Growth
- IAG N/A
- HALO 56.68
- EPS
- IAG 0.59
- HALO 4.74
- Revenue
- IAG $2,234,600,000.00
- HALO $1,242,852,000.00
- Revenue This Year
- IAG $59.71
- HALO $32.47
- Revenue Next Year
- IAG $24.62
- HALO $24.31
- P/E Ratio
- IAG $20.45
- HALO $14.44
- Revenue Growth
- IAG 52.98
- HALO 31.19
- 52 Week Low
- IAG $4.89
- HALO $42.01
- 52 Week High
- IAG $14.67
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- IAG 51.73
- HALO 54.41
- Support Level
- IAG $10.87
- HALO $67.40
- Resistance Level
- IAG $12.86
- HALO $66.97
- Average True Range (ATR)
- IAG 0.51
- HALO 2.01
- MACD
- IAG -0.08
- HALO 0.48
- Stochastic Oscillator
- IAG 64.85
- HALO 66.31
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.